David Sánchez-García

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 13

Top Venues

International journal of molecular sciences

Nanomaterials (Basel, Switzerland)

Drug delivery

Polymers

Institut Químic de Sarrià, Universitat Ramon Llull

Institut Químic de Sarrià (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut Químic de Sarrià, Universitat Ramon Llull

Spain

Profesor Titular (Associate professor) :: Dept. Química Orgánica y Farmacéutica, Grup d'Enginyeria de Materials (GEMAT)

Education History

Institut Químic de Sarrià

Spain

PHD

Publications

Yvette Rabadà, Oriol Bosch-Sanz, Xevi Biarnés, Javier Pedreño, Luis Caveda, David Sánchez-García, Jordi Martorell, Mercedes Balcells
Unravelling the Antifibrinolytic Mechanism of Action of the 1,2,3-Triazole Derivatives. International journal of molecular sciences 25 (13) (2024)
Yvette Rabadà, Oriol Bosch-Sanz, Xevi Biarnés, Javier Pedreño, Luis Caveda, David Sánchez-García, Jordi Martorell, Mercedes Balcells
Unravelling the Antifibrinolytic Mechanism of Action of the 1,2,3-Triazole Derivatives. International journal of molecular sciences 25 (13) (2024)
Oriol Bosch-Sanz, Yvette Rabadà, Xevi Biarnés, Javier Pedreño, Luis Caveda, Mercedes Balcells, Jordi Martorell, David Sánchez-García
1,2,3-Triazole Derivatives as Novel Antifibrinolytic Drugs. International journal of molecular sciences 23 (23) (2022)
Oriol Bosch-Sanz, Yvette Rabadà, Xevi Biarnés, Javier Pedreño, Luis Caveda, Mercedes Balcells, Jordi Martorell, David Sánchez-García
1,2,3-Triazole Derivatives as Novel Antifibrinolytic Drugs. International journal of molecular sciences 23 (23) (2022)
Oriol Bosch-Sanz, Yvette Rabadà, Xevi Biarnés, Javier Pedreño, Luis Caveda, Mercedes Balcells, Jordi Martorell, David Sánchez-García
1,2,3-Triazole Derivatives as Novel Antifibrinolytic Drugs. International journal of molecular sciences 23 (23) (2022)
Oriol Bosch-Sanz, Yvette Rabadà, Xevi Biarnés, Javier Pedreño, Luis Caveda, Mercedes Balcells, Jordi Martorell, David Sánchez-García
1,2,3-Triazole Derivatives as Novel Antifibrinolytic Drugs. International journal of molecular sciences 23 (23) (2022)
Iris Pontón, Andrea Martí Del Rio, Marta Gómez Gómez, David Sánchez-García
Preparation and Applications of Organo-Silica Hybrid Mesoporous Silica Nanoparticles for the Co-Delivery of Drugs and Nucleic Acids. Nanomaterials (Basel, Switzerland) 10 (12) (2020)
Gabriel Martínez-Edo, Cristina Fornaguera, Salvador Borrós, David Sánchez-García
Glycyrrhetinic Acid-Functionalized Mesoporous Silica Nanoparticles for the Co-Delivery of DOX/CPT-PEG for Targeting HepG2 Cells. Pharmaceutics 12 (11) (2020)
Robert Texidó, Gonzalo Anguera, Sergi Colominas, Salvador Borrós, David Sánchez-García
Extended 2,2'-Bipyrroles: New Monomers for Conjugated Polymers with Tailored Processability. Polymers 11 (6) (2019)
Gabriel Martínez-Edo, Maria C Llinàs, Salvador Borrós, David Sánchez-García
Isothiocyanate-Functionalized Mesoporous Silica Nanoparticles as Building Blocks for the Design of Nanovehicles with Optimized Drug Release Profile. Nanomaterials (Basel, Switzerland) 9 (9) (2019)
Maria C Llinàs, Gabriel Martínez-Edo, Anna Cascante, Irene Porcar, Salvador Borrós, David Sánchez-García
Preparation of a mesoporous silica-based nano-vehicle for dual DOX/CPT pH-triggered delivery. Drug delivery 25 (1) (2018)
Gonzalo Anguera, Brice Kauffmann, José I Borrell, Salvador Borrós, David Sánchez-García
Stable 5,5'-Substituted 2,2'-Bipyrroles: Building Blocks for Macrocyclic and Materials Chemistry. The Journal of organic chemistry 82 (13) (2017)
Gonzalo Anguera, David Sánchez-García
Porphycenes and Related Isomers: Synthetic Aspects. Chemical reviews 117 (4) (2016)

David Sánchez-García.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David Sánchez-García